01 42ALPHARMA PHARMS
02 18NALPROPION
03 6PFIZER
01 67682633
02 67682634
03 127815934
04 18088786
05 68158156
06 18318788
07 68623418
08 18722085
09 68846104
10 68877247
11 18916195
12 19107837
13 19125868
14 19248123
15 19633575
16 110231964
17 110307376
18 110403170
19 110828294
20 110835527
21 111033543
22 111139056
23 111324741
24 111998542
25 112048769
01 66Blank
01 31Y
02 35Blank
01 12027-06-04
02 302027-06-19
03 52027-11-08
04 122027-12-12
05 12029-02-03
06 12029-05-29
07 62029-11-07
08 12030-02-02
09 12031-01-10
10 12032-01-13
11 22033-06-05
12 12033-06-25
13 42034-07-02
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 7682633
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8158156
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 7682633
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8158156
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 7682633
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8158156
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
